Drug Profile
Influenza vaccine quadrivalent - Nitto/Osaka
Alternative Names: NSV 0001; Seasonal influenza HA vaccine - Nitto/OsakaLatest Information Update: 25 Oct 2021
Price :
$50
*
At a glance
- Originator Nitto Denko; Osaka University
- Class Influenza virus vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for phase-I development in Influenza-virus-infections(Prevention) in Japan (Sublingual, Tablet)
- 01 Sep 2017 Nitto Denko completes a phase I trial in Influenza virus infections (In adults) in Japan (Sublingual) (NCT02955030)
- 01 Oct 2016 Phase-I clinical trials in Influenza virus infections (In adults) in Japan (Sublingual) (NCT02955030)